pargyline has been researched along with Pulmonary Hypertension in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Plass, R | 1 |
| Günther, KH | 1 |
| Böthig, S | 1 |
| Münster, W | 1 |
1 other study available for pargyline and Pulmonary Hypertension
| Article | Year |
|---|---|
[Clinical features and hemodymanics of primary pulmonary hypertension].
Topics: Adolescent; Adult; Angiocardiography; Diagnosis, Differential; Electrocardiography; Female; Heart Ra | 1968 |